Results 231 to 240 of about 8,441,406 (356)

A Dual Role for NKG7 in T-cell Cytotoxicity and Longevity. [PDF]

Cancer Immunol Res
Dong H, Ham H, Barham W, Wen T, Hirdler JB, Mao Z, Ashton DS, Zhang W, Lucien-Matteoni F, Borges da Silva H, Billadeau DD.   +10 more
europepmc   +1 more source

The Effect of T Cell Growth Factor on the Generation of Cytolytic T Cells [PDF]

, 1978
Paul E. Baker, Steven Gillis, Mary M. Ferm, Kendall A. Smith   +3 more
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

T-cell differentiation stage block bias confers hypermethylation and mediastinal preference in T-cell lymphoblastic lymphoma. [PDF]

Clin Transl Med
Wang J, Qian B, Yu X, Zhang Y, Zhou C, Yang T, Xia L, Zhang G, Zhang YX, Wang Y, Fang Y.   +10 more
europepmc   +1 more source

Macrophage-T Cell Interactions Involving Listeria Monocytogenes—Role of the H-2 Gene Complex [PDF]

, 1979
Andrew G. Farr, Jeanne-Marie Kíely, Emil R. Unanue   +2 more
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Intercellular Nanotube Mitochondrial Transplantation Strategy Mediating T Cell "Supercharging". [PDF]

Research (Wash D C)
Liu B, Chen J, Cui W.
europepmc   +1 more source

The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity. [PDF]

, 1978
M J Berendt, R J North, D P Kirstein
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Radiotherapy for human T-cell leukemia virus type 1-associated adult T-cell leukemia/lymphoma. [PDF]

J Radiat Res
Tokuyama K, Itaya T, Hara A, Tanabe M, Takata S, Kiyota T, Yamate T, Hatano Y, Ogata M, Takano K, Asayama Y.   +10 more
europepmc   +1 more source